Pathogenicity of Candida albicans: quest for a molecular switch
Datta, A.
Brazilian Journal of Medical and Biological Research 27(12): 2721-2732
1994
ISSN/ISBN: 0100-879X PMID: 7549996 Document Number: 423259
Candida albicans is an opportunistic pathogen of human beings and other mammals. Two other features, besides its pathogenicity, have made it a popular organism for study. It exists in different cellular forms and can change from one form to another, depending on growth conditions. Thus, it is being used as a model system to study cellular differentiation. It can also heritably and reversibly switch its cellular and colony morphologies.
Document emailed within 1 workday
Related Documents
Majewski, S.; Macura, A.B. 1983: Biological tests on laboratory animals to determine the pathogenicity of strains of Candida albicans isolated from patients with mycotic denture stomatitis Czasopismo Stomatologiczne 36(3): 217-220Nawaz, A.; Mäkinen, A.; Pärnänen, P.; Meurman, J.H. 2018: Proteolytic activity of non-albicans Candida and Candida albicans in oral cancer patients New Microbiologica 41(4): 296-301
Ngouana, T.K.; Krasteva, D.; Drakulovski, P.; Toghueo, R.K.; Kouanfack, C.; Ambe, A.; Reynes, J.; Delaporte, E.; Boyom, F.F.; Mallié, M.èl.; Bertout, S.éb. 2015: Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients Mycoses 58(1): 33-39
Calderone, R.A. 1993: Molecular interactions at the interface of Candida albicans and host cells Archives of Medical Research 24(3): 275-279
Budak, A. 1990: Epidemiology of Candida infection. III. A proposal for a new typing system for Candida albicans strains Archivum Immunologiae et Therapiae Experimentalis 38(5-6): 379-385
Tamura, M.; Watanabe, K.; Imai, T.; Mikami, Y.; and Kazuko Nishimula 2000: New PCR Primer Pairs Specific for Candida dubliniensis and Detection of the Fungi from the Candida albicans Clinical lsolates in Japan Clinical Laboratory 46(1-2): 33-40
Bäuerle, M.; Schröppel, K.; Taylor, B.; Bergmann, S.; Schmitt-Haendle, M.; Harrer, T. 2006: Analysis of the Candida albicans - specific T-cell response and oropharyngeal Candida colonization in a cohort of HIV-1-infected patients European Journal of Medical Research 11(11): 479-484
Silard, R.; Panaitescu, D. 1973: In vitro study of the relationship between Entamoeba histolytica and Candida albicans. I. Aspects of phagocytosis of C. albicans by E. histolytica. (Preliminary note) Archives Roumaines de Pathologie Experimentales et de Microbiologie 32(2): 211-218
Paiva, L.C.Farias.; Donatti, Lélia.; Patussi, E.V.; Svizdinski, T.I.E.; Lopes-Consolaro, Márcia.E. 2010: Scanning electron and confocal scanning laser microscopy imaging of the ultrastructure and viability of vaginal Candida albicans and non- albicans species adhered to an intrauterine contraceptive device Microscopy and Microanalysis: the Official Journal of Microscopy Society of America Microbeam Analysis Society Microscopical Society of Canada 16(5): 537-549
Hua, S.; Huang, J.; Wu, Z.; Feng, Z. 2012: A comparison study between Candida parapsilosis sepsis and Candida albicans sepsis in preterm infants Turkish Journal of Pediatrics 54(5): 502-508
Baker, J.G.; Salkin, I.F.; Pincus, D.H.; Bodensteiner, D.C.; D'Amato, R.F. 1983: Pathogenicity of Candida paratropicalis Archives of Pathology and Laboratory Medicine 107(11): 577-579
De Haller, R. 1977: Pathogenicity of Aspergillus and Candida Praxis und Klinik der Pneumologie 31(5): 539-545
Ruzicka, D.J.; Kuroishi, N.; Oshima, N.; Sakuma, R.; Naito, T. 2019: Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database Bmc Infectious Diseases 19(1): 505
Banerjee, U.; Kumar, R.; Mohapatra, L.N. 1984: Assessment of pathogenicity of C. albicans. Determination of fifty percent infective dose [ID50] for mice Indian Journal of Pathology and Microbiology 27(4): 289-294
Mouchet, A. 1974: Candida albicans septicemia Chirurgie; Memoires de l'Academie de Chirurgie 100(1): 87-88
Hagert, M.; Flögel, K.; Schönborn, C.; Engelmann, L.; Schneider, D. 1974: Candida albicans sepsis Zeitschrift für die Gesamte Innere Medizin und Ihre Grenzgebiete 29(17): 692-696
Tiberghien, F.; De-Seze, J.; Stojkovic, T.; Delmaire, C.; Gauvrit, J.Y.; Sendid, B.; Vermersch, P. 2002: Candida albicans meningoencephalomyeloradiculitis Revue Neurologique (Paris) 158(4): 473-476
Tuttobello, L.; Palliola, E. 1979: Significance and limitations of the tests of pathogenicity of Candida Annali Dell'istituto Superiore di Sanita 15(3): 423-437
Perea, S. 2000: Azole resistance in Candida albicans Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 13(3): 314-317
Durakovic, Z.; Durakovic, S. 1979: The effect of rosemary oil on Candida albicans Journal of the Indian Medical Association 72(7): 175-176